Yu Wu, Jiahong Pei, Hanzhuo Wang, Mei Yu, Dandan Wang
{"title":"Development of a KRP-based pH-responsive drug delivery system for solid tumors.","authors":"Yu Wu, Jiahong Pei, Hanzhuo Wang, Mei Yu, Dandan Wang","doi":"10.21037/tcr-2025-1151","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cell-penetrating peptides (CPPs) are considered ideal carriers for the delivery of drugs through the cell membrane barrier, with enhanced permeation and retention effects. These peptides can increase the bioavailability of drugs and reduce their side effects. In this study, we developed a polypeptide called \"cell-penetrating peptide (KRP)\", linked it with doxorubicin (DOX), and created a pH-responsive triggered drug delivery system called \"KRP-Hyd-DOX\".</p><p><strong>Methods: </strong>We generated KRP through the application of standard Fmoc solid-phase peptide synthesis (SPPS). We attached DOX through a stable amide bond, using 3-maleimidopropionic acid as a linker, yielding KRP-DOX. With 6-maleimidopropionic acid as a linker, we connected DOX via a pH-sensitive hydrazone bond, resulting in KRP-Hyd-DOX. The pH-responsive drug-release performance of KRP-Hyd-DOX was evaluated through the calculation of the cumulative release of DOX at various time intervals and under different pH conditions via the DOX standard curve in the corresponding buffer. The cell penetration and cytotoxicity of KRP-Hyd-DOX, KRP-DOX, and DOX-hydrochloride (HCL) were compared.</p><p><strong>Results: </strong>The efficiency of KRP-DOX and KRP-Hyd-DOX in releasing free DOX was approximately 30% after 24 hours under pH 7.4. Under pH 5.0, the efficiency of KRP-DOX in releasing free DOX did not change significantly as compared to that at pH 7.4, while the efficiency of KRP-Hyd-DOX in releasing free DOX increased to 65% after 24 hours. After 24-hour exposure to KRP-Hyd-DOX, KRP-DOX, and DOX-HCL across different concentrations, MG63 cell viability exhibited a dose-dependent decline. The half-maximal inhibitory concentration (IC50) of KRP-Hyd-DOX (MG63 cells/5.22 µM) was less than that of KRP-DOX (MG63 cells/7.41 µM).</p><p><strong>Conclusions: </strong>The system we created (KRP-Hyd-DOX) leverages the synergistic effect of KRP and DOX, enhancing efficacy while minimizing side effects.</p>","PeriodicalId":23216,"journal":{"name":"Translational cancer research","volume":"14 6","pages":"3812-3821"},"PeriodicalIF":1.5000,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12268649/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational cancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/tcr-2025-1151","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/27 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Cell-penetrating peptides (CPPs) are considered ideal carriers for the delivery of drugs through the cell membrane barrier, with enhanced permeation and retention effects. These peptides can increase the bioavailability of drugs and reduce their side effects. In this study, we developed a polypeptide called "cell-penetrating peptide (KRP)", linked it with doxorubicin (DOX), and created a pH-responsive triggered drug delivery system called "KRP-Hyd-DOX".
Methods: We generated KRP through the application of standard Fmoc solid-phase peptide synthesis (SPPS). We attached DOX through a stable amide bond, using 3-maleimidopropionic acid as a linker, yielding KRP-DOX. With 6-maleimidopropionic acid as a linker, we connected DOX via a pH-sensitive hydrazone bond, resulting in KRP-Hyd-DOX. The pH-responsive drug-release performance of KRP-Hyd-DOX was evaluated through the calculation of the cumulative release of DOX at various time intervals and under different pH conditions via the DOX standard curve in the corresponding buffer. The cell penetration and cytotoxicity of KRP-Hyd-DOX, KRP-DOX, and DOX-hydrochloride (HCL) were compared.
Results: The efficiency of KRP-DOX and KRP-Hyd-DOX in releasing free DOX was approximately 30% after 24 hours under pH 7.4. Under pH 5.0, the efficiency of KRP-DOX in releasing free DOX did not change significantly as compared to that at pH 7.4, while the efficiency of KRP-Hyd-DOX in releasing free DOX increased to 65% after 24 hours. After 24-hour exposure to KRP-Hyd-DOX, KRP-DOX, and DOX-HCL across different concentrations, MG63 cell viability exhibited a dose-dependent decline. The half-maximal inhibitory concentration (IC50) of KRP-Hyd-DOX (MG63 cells/5.22 µM) was less than that of KRP-DOX (MG63 cells/7.41 µM).
Conclusions: The system we created (KRP-Hyd-DOX) leverages the synergistic effect of KRP and DOX, enhancing efficacy while minimizing side effects.
期刊介绍：
Translational Cancer Research (Transl Cancer Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803; http://tcr.amegroups.com/) is an Open Access, peer-reviewed journal, indexed in Science Citation Index Expanded (SCIE). TCR publishes laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer; results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of cancer patients. The focus of TCR is original, peer-reviewed, science-based research that successfully advances clinical medicine toward the goal of improving patients'' quality of life. The editors and an international advisory group of scientists and clinician-scientists as well as other experts will hold TCR articles to the high-quality standards. We accept Original Articles as well as Review Articles, Editorials and Brief Articles.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
